Cogent Biosciences (COGT) EBT Margin (2017 - 2020)
Cogent Biosciences (COGT) posted quarterly EBT Margin of 20362.82% for Q3 2020, down 1899086.0% year-over-year from N/an in Q4 2019, and down 1352.91% quarter-over-quarter from 1401.52% in Q2 2020.
Cogent Biosciences (COGT) EBT Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has reported EBT Margin for 4 consecutive years, with 20362.82% the latest figure, recorded in Q3 2020.
- In Q3 2020, EBT Margin fell 1899086.0% year-over-year to 20362.82%; the TTM figure through Dec 2020 stood at 1133.54% (down 96620.0% YoY), while the FY2020 annual figure was 1090.23%, down 91881.0% from the prior year.
- EBT Margin retreated to 20362.82% in Q3 2020 per COGT's latest filing, from 1401.52% in the prior quarter.
- Across five years, EBT Margin topped out at 9.62% in Q4 2019 and bottomed at 20362.82% in Q3 2020.
- Historically, EBT Margin has averaged 1814.3% across 4 years, with a median of 364.25% in 2017.
- On a YoY basis, EBT Margin climbed as much as 32594 bps in 2020 and fell as far as 1899086 bps in 2020.
- Cogent Biosciences' EBT Margin stood at 364.25% in 2017, then advanced by 25 bps to 274.22% in 2018, then soared by 104 bps to 9.62% in 2019, then tumbled by 211873 bps to 20362.82% in 2020.
- Business Quant data shows COGT's EBT Margin at 20362.82% in Q3 2020, 1401.52% in Q2 2020, and 86.67% in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -20,362.82% |
| Jun 30, 2020 | -1,401.52% |
| Mar 31, 2020 | -86.67% |
| Dec 31, 2019 | 9.62% |
| Sep 30, 2019 | -1,371.96% |
| Jun 30, 2019 | -399.24% |
| Mar 31, 2019 | -412.61% |
| Dec 31, 2018 | -274.22% |
| Sep 30, 2018 | -597.99% |
| Jun 30, 2018 | -682.95% |
| Mar 31, 2018 | -345.32% |
| Dec 31, 2017 | -364.25% |
| Sep 30, 2017 | -306.78% |
| Jun 30, 2017 | -290.52% |
| Mar 31, 2017 | -327.26% |